These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 26745140

  • 1. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
    Zhao S, Tang J, Shao S, Yan Y.
    Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
    [Abstract] [Full Text] [Related]

  • 2. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
    Park YW, Kim SB, Kwon H, Kang HC, Cho K, Lee KI, Kim YJ, Lee JH.
    Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
    [Abstract] [Full Text] [Related]

  • 3. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
    Gacci M, Vignozzi L, Sebastianelli A, Salvi M, Giannessi C, De Nunzio C, Tubaro A, Corona G, Rastrelli G, Santi R, Nesi G, Serni S, Carini M, Maggi M.
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
    [Abstract] [Full Text] [Related]

  • 4. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
    Haghsheno MA, Mellström D, Peeker R, Hammarsten J, Lorentzon M, Sundh V, Karlsson M, Ohlsson C, Damber JE.
    Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
    [Abstract] [Full Text] [Related]

  • 5. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH, Kim Y, Park YW, Lee DG.
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [Abstract] [Full Text] [Related]

  • 6. The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study.
    Fu Y, Zhou Z, Yang B, Zhang K, He L, Zhang X.
    Urol Int; 2016 May; 97(3):330-335. PubMed ID: 27509202
    [Abstract] [Full Text] [Related]

  • 7. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S, Chen C, Chen Z, Xia M, Tang J, Shao S, Yan Y.
    Urol J; 2016 Jun 28; 13(3):2717-26. PubMed ID: 27351328
    [Abstract] [Full Text] [Related]

  • 8. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH, Kwon H, Park YW.
    Urology; 2013 Nov 28; 82(5):1008-12. PubMed ID: 24041675
    [Abstract] [Full Text] [Related]

  • 9. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
    De Nunzio C, Cindolo L, Gacci M, Pellegrini F, Carini M, Lombardo R, Franco G, Tubaro A.
    Urology; 2014 Nov 28; 84(5):1181-7. PubMed ID: 25443931
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms.
    Kwon H, Kang HC, Lee JH.
    Urology; 2013 Jun 28; 81(6):1325-9. PubMed ID: 23602796
    [Abstract] [Full Text] [Related]

  • 12. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
    Zhang W, Li Z, Liu M, Mu Y, He J, Chen P, Liu D, Chen K, Che B, Xu S, Zhang H, Tang K.
    World J Urol; 2021 Dec 28; 39(12):4413-4419. PubMed ID: 34228163
    [Abstract] [Full Text] [Related]

  • 13. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG, Barkin J, Tubaro A, Emberton M, Wilson TH, Brotherton BJ, Castro R.
    BJU Int; 2014 Apr 28; 113(4):623-35. PubMed ID: 24127818
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes.
    Caretta N, Vigili de Kreutzenberg S, Valente U, Guarneri G, Pizzol D, Ferlin A, Avogaro A, Foresta C.
    Andrology; 2015 Nov 28; 3(6):1062-7. PubMed ID: 26339755
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, Tubaro A, Oelke M, Carini M, Maggi M.
    BJU Int; 2015 Jan 28; 115(1):24-31. PubMed ID: 24602293
    [Abstract] [Full Text] [Related]

  • 19. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
    Ozer K, Horsanali MO, Gorgel SN, Horsanali BO, Ozbek E.
    Urol Int; 2017 Jan 28; 98(4):466-471. PubMed ID: 27464069
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.